Article Details
Retrieved on: 2022-08-26 17:30:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Adjuvant treatment for patients With BRCA-mutated, HER2-negative high recurrent risk breast cancer. image credit- shutterstock. AstraZeneca and ...
Article found on: www.biospectrumasia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here